drugset / Trial / NCT03178929

Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma

NCT03178929

RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this study is to explore the effect of SAMe on recurrence after radical treatment of Primary liver cancer.

Timeline

Start
2017-07-01
Primary completion
2020-07-01
Completion
2020-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject S-adenosylmethionine Other / unclassified 2000 mg Oral

Indications